Carnitine deficiency

Carnitine deficiency is a metabolic disorder characterized by inadequate cellular levels of carnitine, an essential compound required for the transport of long-chain fatty acids into mitochondria for beta-oxidation and energy production The condition primarily impacts organs with high energy demands—specifically the skeletal musculature, myocardium, liver, and central nervous system—affecting pediatric and adult populations Hallmark pathophysiologic and clinical features include hypoketotic hypo...

Carnitine deficiency is a metabolic disorder characterized by inadequate cellular levels of carnitine, an essential compound required for the transport of long-chain fatty acids into mitochondria for beta-oxidation and energy production

It can occur as a primary autosomal recessive genetic disorder caused by defective cell membrane carnitine transport, or as a secondary deficiency arising from other inborn errors of metabolism, chronic hemodialysis, total parenteral nutrition, or certain medications

It can occur as a primary autosomal recessive genetic disorder caused by defective cell membrane carnitine transport, or as a secondary deficiency arising from other inborn errors of metabolism, chronic hemodialysis, total parenteral nutrition, or certain medications

The condition primarily impacts organs with high energy demands—specifically the skeletal musculature, myocardium, liver, and central nervous system—affecting pediatric and adult populations

The condition primarily impacts organs with high energy demands—specifically the skeletal musculature, myocardium, liver, and central nervous system—affecting pediatric and adult populations

Hallmark pathophysiologic and clinical features include hypoketotic hypoglycemia, hyperammonemia, hepatic dysfunction, progressive cardiomyopathy, skeletal muscle weakness, and, during periods of metabolic stress or prolonged fasting, acute encephalopathy

Hallmark pathophysiologic and clinical features include hypoketotic hypoglycemia, hyperammonemia, hepatic dysfunction, progressive cardiomyopathy, skeletal muscle weakness, and, during periods of metabolic stress or prolonged fasting, acute encephalopathy